Protalix BioTherapeutics Inc (PLX)
1.10
-0.15
(-12.00%)
USD |
NYAM |
May 10, 16:00
1.11
+0.01
(+0.91%)
After-Hours: 20:00
Protalix BioTherapeutics Price to Book Value: 2.394 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 10, 2024 | 2.394 |
May 09, 2024 | 2.720 |
May 08, 2024 | 2.481 |
May 07, 2024 | 2.481 |
May 06, 2024 | 2.416 |
May 03, 2024 | 2.481 |
May 02, 2024 | 2.524 |
May 01, 2024 | 2.633 |
April 30, 2024 | 2.481 |
April 29, 2024 | 2.611 |
April 26, 2024 | 2.503 |
April 25, 2024 | 2.568 |
April 24, 2024 | 2.633 |
April 23, 2024 | 2.611 |
April 22, 2024 | 2.568 |
April 19, 2024 | 2.503 |
April 18, 2024 | 2.459 |
April 17, 2024 | 2.503 |
April 16, 2024 | 2.481 |
April 15, 2024 | 2.481 |
April 12, 2024 | 2.568 |
April 11, 2024 | 2.655 |
April 10, 2024 | 2.742 |
April 09, 2024 | 2.873 |
April 08, 2024 | 2.829 |
Date | Value |
---|---|
April 05, 2024 | 2.546 |
April 04, 2024 | 2.633 |
April 03, 2024 | 2.698 |
April 02, 2024 | 2.698 |
April 01, 2024 | 2.720 |
March 28, 2024 | 2.742 |
March 27, 2024 | 2.720 |
March 26, 2024 | 2.655 |
March 25, 2024 | 2.655 |
March 22, 2024 | 2.764 |
March 21, 2024 | 2.873 |
March 20, 2024 | 2.916 |
March 19, 2024 | 2.829 |
March 18, 2024 | 2.764 |
March 15, 2024 | 2.894 |
March 14, 2024 | 2.981 |
March 13, 2024 | 3.308 |
March 12, 2024 | 3.112 |
March 11, 2024 | 3.134 |
March 08, 2024 | 3.242 |
March 07, 2024 | 3.177 |
March 06, 2024 | 3.221 |
March 05, 2024 | 3.308 |
March 04, 2024 | 3.417 |
March 01, 2024 | 3.525 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.394
Minimum
May 10 2024
284.46
Maximum
Sep 30 2021
56.35
Average
6.946
Median
Jun 03 2021
Price to Book Value Benchmarks
Agenus Inc | -- |
InfuSystems Holdings Inc | 2.960 |
AIM ImmunoTech Inc | 2.091 |
Perspective Therapeutics Inc | 13.66 |
Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
PE Ratio | 55.00 |
PS Ratio | 1.306 |
Price | 1.10 |
Earnings Yield | 1.82% |
Market Cap | 80.36M |
Operating PE Ratio | 8.177 |
Normalized PE Ratio | 55.00 |